OBJECTIVE: This work aims to explore the short-term efficacy and safety of coronary arterial injection of tirofiban in elderly diabetic patients complicated with acute myocardial infarction (AMI) who underwent emergency percutaneous coronary intervention (PCI). METHODS:Ninety-seven elderly diabetic patients complicated with ST-elevation myocardial infarction (STEMI) who underwent emergency PCI were selected and randomized into control (group A, 49 cases) and tirofiban (group B, 48 cases) groups. Another 129 nonelderly diabetic patients (group C) complicated with STEMI who underwentemergency PCI and tirofiban treatment in the corresponding period were also involved for comparison. RESULTS:Thrombolysis in myocardial infarction3 (TIMI3) flow was significantly higher in groups B and C than in group A after PCI (p < 0.01). TIMI myocardial perfusion grades (TMPG) 0 to 1 and 2 were distinctly lower (p < 0.01, p < 0.05) and TMPG3 was obviously higher (p < 0.01) in groups B and C than in group A. The average length of hospital stay, post-infarction angina pectoris, severe arrhythmia, and cardiac function Killip III to IV were markedly lower in groups B and C than in group A (p < 0.01, p < 0.05). Meanwhile, mucocutaneous hemorrhage was significantly higher in groups B and C than in group A (p < 0.01). CONCLUSIONS:Tirofiban effectively improved TIMI flow and TMPG perfusion in elderly diabetic patients complicated with AMI and reduced the incidence of serious complications without increasing the occurrence of severe hemorrhage. KEY WORDS: Acute myocardial infarction; Diabetes mellitus; Emergencypercutaneous coronary intervention; Tirofiban.
RCT Entities:
OBJECTIVE: This work aims to explore the short-term efficacy and safety of coronary arterial injection of tirofiban in elderly diabeticpatients complicated with acute myocardial infarction (AMI) who underwent emergency percutaneous coronary intervention (PCI). METHODS: Ninety-seven elderly diabeticpatients complicated with ST-elevation myocardial infarction (STEMI) who underwent emergency PCI were selected and randomized into control (group A, 49 cases) and tirofiban (group B, 48 cases) groups. Another 129 nonelderly diabeticpatients (group C) complicated with STEMI who underwent emergency PCI and tirofiban treatment in the corresponding period were also involved for comparison. RESULTS:Thrombolysis in myocardial infarction 3 (TIMI3) flow was significantly higher in groups B and C than in group A after PCI (p < 0.01). TIMI myocardial perfusion grades (TMPG) 0 to 1 and 2 were distinctly lower (p < 0.01, p < 0.05) and TMPG3 was obviously higher (p < 0.01) in groups B and C than in group A. The average length of hospital stay, post-infarction angina pectoris, severe arrhythmia, and cardiac function Killip III to IV were markedly lower in groups B and C than in group A (p < 0.01, p < 0.05). Meanwhile, mucocutaneous hemorrhage was significantly higher in groups B and C than in group A (p < 0.01). CONCLUSIONS:Tirofiban effectively improved TIMI flow and TMPG perfusion in elderly diabeticpatients complicated with AMI and reduced the incidence of serious complications without increasing the occurrence of severe hemorrhage. KEY WORDS: Acute myocardial infarction; Diabetes mellitus; Emergency percutaneous coronary intervention; Tirofiban.
Authors: Gabriel Greenberg; Abid Assali; Hanna Assa-Vaknin; David Brosh; Igal Teplitsky; Alexander Battler; Ran Kornowski; Eli I Lev Journal: Cardiology Date: 2012-06-22 Impact factor: 1.869
Authors: Sonja Postma; Ton Heestermans; Jurrien W Ten Berg; Jochem W van Werkum; Harry Suryapranata; Yochai Birnbaum; Christian W Hamm; Arnoud W J van 't Hof Journal: J Electrocardiol Date: 2011 Sep-Oct Impact factor: 1.438
Authors: Kathryn A Britton; Vikas Aggarwal; Anita Y Chen; Karen P Alexander; Ezra Amsterdam; Elizabeth Fraulo; Paul Muntner; Laine Thomas; Darren K McGuire; Stephen D Wiviott; Matthew T Roe; Ulrich K Schubart; Caroline S Fox Journal: Am Heart J Date: 2011-04 Impact factor: 4.749
Authors: J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook Journal: Circulation Date: 1987-07 Impact factor: 29.690
Authors: Giovanni Paolo Talarico; Marta Brancati; Francesco Burzotta; Italo Porto; Carlo Trani; Maria De Vita; Daniel Todaro; Maura Giammarinaro; Antonio Maria Leone; Giampaolo Niccoli; Felicita Andreotti; Mario Attilio Mazzari; Giovanni Schiavoni; Filippo Crea Journal: J Cardiovasc Med (Hagerstown) Date: 2009-03 Impact factor: 2.160